Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development) - Image 1

£149.75

Humana Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Name: Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
Brand: Humana
Price: 149.75 GBP
Availability: InStock

Optometry - Opticians

This is the usual price. Wait for it to drop, or tell us your number.

£150 today · usual range £0–£0 · best ever £49

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 584 days • 584 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 584 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £128-154 (328 days, 56.2%)

Price range: £49 - £180

Price levels: 5 price ranges over 584 days

Description

Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of identifying molecules that have the potential to be therapeutically important in human malignant disease. "Screening" remains the most important and most controversial method in cancer drug discovery. In vitro screens have generally focused on cytotoxicity and have identified several highly cytotoxic molecules. Other endpoints available in vitro are inhibition of proliferation, 3 inhibition of [ H]thymidine incorporation into DNA and various viability assays, based most frequently on dye exclusion or metabolism. Review "...extremely readable...excellent treatment of drugs such as naphthalimides...Each chapter is succinct and well-written." -Cancer Forum "...a most important source of literature for all those who are involved in basic cancer research and in the clinical care of cancer patients in different fields of medicine." -Haematologia

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1617370460
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Optometry - Opticians
Domain: Amazon UK
Publication Date: 19 November 2010
Listed Since: 11 July 2010

Barcode

No barcode data available

Humana Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Wiley Anticancer Therapeutics - Oncology Drug Design Book

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Cancer Chemotherapy: Basic Science to the Clinic

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Medicinal Chemistry of Anticancer Drugs

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Oxford Textbook of Cancer Biology (Oxford Textbooks in Oncology)

Springer Cancer Chemotherapy Volume 36 - Research Series

Holland-Frei Cancer Medicine - Volume 1 and 2

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Cancer Drug Design and Discovery

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)